SARS-CoV-2 variant of concern type and biological sex affect efficacy of molnupiravir in dwarf hamster model of severe COVID-19
C. M. Lieber, R. Cox, J. Sourimant, J. D. Wolf, K. Juergens, Q. Phung, M. T. Saindane, M. G. Natchus, G. R. Painter, K. Sakamoto, A. L. Greninger, R. K. Plemper
This study evaluates molnupiravir efficacy against SARS-CoV-2 variants in different models, finding VOC-dependent efficacy and sex-based differences in dwarf hamsters.
bioRxiv · Feb 4, 2022 · PreprintMicrobiology